Medicus Pharma News

Wall Street Set to Open Higher Friday as Inflation Data Meets Expectations

MT NewswiresFeb 28 09:20 ET

US Stock Futures Rise as Investors Await Key Inflation Data

MT NewswiresFeb 28 08:09 ET

Extended Session Rally For Medicus (MDCX) Stock, Fueled By Regulatory Success

Stocks TelegraphFeb 28 04:12 ET

Market Movers: Ideal Power, Tiziana Life Sciences, Medicus Pharma...

Proactive InvestorsFeb 27 15:40 ET

Medicus Pharma Expands Basal Cell Carcinoma Trial in the Middle East | NASDAQ:MDCX, TSX-V:MDCX

Proactive InvestorsFeb 27 09:29 ET

Medicus Pharma Shares Are Trading Higher After the Company Announced It Submitted a Phase 2 Clinical Design for SKNJCT-004 to the UAE Department of Health (DOH).

BenzingaFeb 27 09:07 ET

Express News | Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (Sknjct-004) to United Arab Emirates (UAE) Department of Health (Doh) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (Bcc)

ReutersFeb 27 07:31 ET

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

newsfileFeb 27 07:30 ET

News On Medicus Pharma Ltd. (MDCX.V) Now Under MDCX

Dow JonesFeb 26 17:08 ET

Maxim Group Maintains Medicus Pharma(MDCX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsFeb 19 08:34 ET · Ratings

Medicus Pharma Ltd Poised for Growth: Buy Rating Reaffirmed Amid Promising Developments and Upcoming Catalysts

TipRanksFeb 19 08:05 ET · Ratings

Promising Phase 2 Study and Innovative Approach Boost Confidence in Medicus Pharma Ltd.

TipRanksFeb 15 13:05 ET

Medicus Pharma Expects Interim Data From Phase 2 Skin Cancer Trial by Quarter-end | NASDAQ:MDCX, TSX-V:MDCX

Proactive InvestorsFeb 14 08:40 ET

Express News | Medicus Pharma Ltd. Announce That Its Phase 2 Clinical Study (SKNJCT-003) Which Is Currently Underway In Nine Clinical Sites In United States, Has Now Randomized More Than 50% Of 60 Patients Expected To Be Enrolled In The Study

BenzingaFeb 14 07:32 ET

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

newsfileFeb 14 07:30 ET

Medicus Pharma Announces Equity Deal, Shifts Focus to Nasdaq | NASDAQ:MDCX, TSX-V:MDCX

Proactive InvestorsFeb 11 09:32 ET

Medicus Pharma Announces Standby Equity Purchase Deal, To Delist From TSX Venture Exchange

RTTNewsFeb 11 08:42 ET

Medicus Pharma Brief: Says Has Entered Into Standby Equity Purchase Agreement and Announced Intention to Voluntarily Delist From the TSX Venture Exchange (TSXV)

MT NewswiresFeb 11 08:30 ET

Medicus Pharma Secures $15M Equity Purchase Agreement With Yorkville Advisors

BenzingaFeb 11 07:33 ET

Tariffs Expected to Bring Pharmaceutical Price Bumps, Shortages -- Market Talk

WSJFeb 10 10:43 ET